NCT00918177 - An Evaluation of the Pharmacokinetics and Pharmacodynamics of AP09004 in Patients With Parkinson's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

October 31, 2012

Conditions

Parkinson's Disease

Interventions

DRUG

AP09004

DRUG

Carbidopa/Levodopa, immediate release

Trial Locations (7)

Barzilai Medical Center, Department of Neurology, Movement disorders unit,, Ashkelon

Department of Neurology, Clalit University Medical Center, Beersheba

Rambam Health Care Campus, Haifa, Movement Disorders and Parkinson's Disease, Haifa

Edith Wolfson , Dept. of Neurology, Movement Disorders Unit., Holon

Rabin Medical Center, Petah Tikva

Sheba Medical Center, Ramat Gan

TASMC, Tel Aviv